Navigating 10^1000 variants was impossible. A model designed novel proteins, boosting stem cell marker expression >50x over controls.
A longevity biotech startup working to extend human healthspan by optimizing the proteins responsible for cellular reprogramming and rejuvenation.
The standard reprogramming process is notoriously inefficient, with conversion rates typically below 0.1% and timelines exceeding three weeks....
“When researchers bring deep domain insight to our language-model tooling, problems that once took years can shift in days. We look forward to seeing what other advances emerge as more teams pair their expertise with the models we’re building.”
Biotechnology firm targeting cellular aging to increase healthy human lifespan.
AI research and deployment company developing generative models and tools.
Retro Biosciences's Protein engineering is part of this use case:
Related implementations across industries and use cases
Matching phages required screening trillions of options. Gen AI simulates interactions, cutting discovery from 10 years to 2 months.
Physics simulations took weeks to screen libraries. Boltz-2 runs 1,000x faster, cutting this to hours with 2x precision.
Writers spent weeks sifting through data to draft reports. AI now generates a 14-section first draft in minutes for review.
Matching phages required screening trillions of options. Gen AI simulates interactions, cutting discovery from 10 years to 2 months.
Physics simulations took weeks to screen libraries. Boltz-2 runs 1,000x faster, cutting this to hours with 2x precision.
Insurance bottlenecks delayed critical therapies for months. Now, AI verifies coverage, freeing care teams to guide patients to treatment.
Manual scheduling trapped recruiters in logistics. AI now automates interview coordination, freeing teams for strategic work.
A 200% yearly data expansion bottlenecked global operations. Now, AI accelerates coding, drafts recipe cards, and resolves inquiries.
Moderation couldn't keep pace with 600M users. AI agents now filter toxicity while models recognize 2.5B objects to refine search.
Navigating 10^1000 variants was impossible. A model designed novel proteins, boosting stem cell marker expression >50x over controls.
A longevity biotech startup working to extend human healthspan by optimizing the proteins responsible for cellular reprogramming and rejuvenation.
The standard reprogramming process is notoriously inefficient, with conversion rates typically below 0.1% and timelines exceeding three weeks....
“When researchers bring deep domain insight to our language-model tooling, problems that once took years can shift in days. We look forward to seeing what other advances emerge as more teams pair their expertise with the models we’re building.”
Biotechnology firm targeting cellular aging to increase healthy human lifespan.
AI research and deployment company developing generative models and tools.
Retro Biosciences's Protein engineering is part of this use case:
Related implementations across industries and use cases
Matching phages required screening trillions of options. Gen AI simulates interactions, cutting discovery from 10 years to 2 months.
Physics simulations took weeks to screen libraries. Boltz-2 runs 1,000x faster, cutting this to hours with 2x precision.
Writers spent weeks sifting through data to draft reports. AI now generates a 14-section first draft in minutes for review.
Matching phages required screening trillions of options. Gen AI simulates interactions, cutting discovery from 10 years to 2 months.
Physics simulations took weeks to screen libraries. Boltz-2 runs 1,000x faster, cutting this to hours with 2x precision.
Insurance bottlenecks delayed critical therapies for months. Now, AI verifies coverage, freeing care teams to guide patients to treatment.
Manual scheduling trapped recruiters in logistics. AI now automates interview coordination, freeing teams for strategic work.
A 200% yearly data expansion bottlenecked global operations. Now, AI accelerates coding, drafts recipe cards, and resolves inquiries.
Moderation couldn't keep pace with 600M users. AI agents now filter toxicity while models recognize 2.5B objects to refine search.